3,554
Views
120
CrossRef citations to date
0
Altmetric
Original Articles

Walnuts (Juglans regia) Chemical Composition and Research in Human Health

, , &

REFERENCES

  • Ailhaud, G., Guesnet, P. and Cunnane, S. C. (2008). An emerging risk factor for obesity: Does disequilibrium of polyunsaturated fatty acid metabolism contribute to excessive adipose tissue development? Br. J. Nutr. 100:461–470.
  • Alasalvar, C. and Shahidi, F. (2008). Tree Nuts: Composition, Phytochemicals, and Health Effects. CRC Press, Boca Raton, FL.
  • American Diabetes Association (2004): Nutrition principles and recommendations in diabetes (Position Statement). Diabetes Care 27(Suppl. 1): S36–S46.
  • Anderson, R. J., Freedland, K. E., Clouse, R. E. and Lustman, P. J. (2001). The prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care. 24:1069–1078.
  • Aronis, K. N., Vamvini, M. T. and Chamberland, J. P. (2011). Short-term walnut consumption increases circulating total adiponectin and apolipoprotein a concentrations, but does not affect markers of inflammation or vascular injury in obese humans with the metabolic syndrome: Data from a double blinded, randomized, placebo-controlled study. Metabolism. 61:577–582.
  • Arsenault, B. J., Despres, J. P., Stroes, E. S., Wareham, N. J. and Kastelein, J. J. (2010). Lipid assessment, metabolic syndrome and coronary heart disease risk. Eur. J. Clin. Invest. 40:1081–1093.
  • Asadi Shekaari, M., Kalantaripour, T. P., Arab, N. F., Namazian, E. and Eslami, A. (2012). The anticonvulsant and neuroprotective effects of walnuts on the neurons of rat brain cortex. Avicenna J. Med. Biotech. (AJMB) 4:155–158.
  • Astrup, A., Dyerberg, J. and Elwood, P. (2011). The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: Where does the evidence stand in 2010? Am. J. Clin. Nutr. 93:684–688.
  • Bhargava, U. C. and Westfall, B. A. (1968). Antitumor activity of Juglans nigra (Black Walnut) extractives. J. Pharm. Sci. 57:1674–1677.
  • Barnett, A. H. (2009). New treatments in type 2 diabetes: A focus on the incretin-based therapies. Clin. Endocrinol. 70:343–353.
  • Bartsch, H., Nair, J. and Owen, R. W. (1999). Dietary PUFAs and cancer of the breast and colorectum: Compelling evidence for their role as risk modifiers. Carcinogenesis. 20:2209–2218.
  • Bashkatova, V., Narkevich, V., Vitskova, G., and Vanin, A. (2003). The influence of anticonvulsant and antioxidant drugs on nitric oxide level and lipid peroxidation in the rat brain during penthylenetetrazole-induced epileptiform model seizures. Prog Neuro-Psychopharmacol. Biol. Psychiatry. 27:487–492.
  • Bate-Smith, E. C. (1972). Detection and determination of ellagitannins. Phytochemistry. 11:1153–1156.
  • Baur, J. A. and Sinclair, D. A. (2006). Therapeutic potential of resveratrol: The in vivo evidence. Nature Rev. Drug Discov. 5:493–506.
  • Begin, M. E., Das, U. N., Ells, G. and Horrobin, D. F. (1985). Selective killing of human cancer cells by polyunsaturated fatty acids. Prostaglandins Leukot. Med. 19:177–186.
  • Berquin, I.M., Edwards, I.J. and Chen, Y.Q. (2008). Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Letters. 269(2):363–377.
  • Bingham, E. and Morris, S. (1988). Complex mixtures and multiple agent interactions: The issues and their significance. Fundam. Appl. Toxol. 10:549–552.
  • Bolling, B. W., Chen, C. Y. O., McKay, D. L. and Blumberg, J. B. (2011). The phytochemical composition of tree nuts. Nutr. Res. Rev. 24:244–275.
  • Boukharta, M., Jalbert, G. and Castonguay, A. (1992). Biodistribution of ellagic acid and dose-related inhibition of lung tumorigenesis in A/J mice. Nutr. Cancer. 18:181–189.
  • Brennan, A. M., Sweeney, L. L., Liu, X. and Mantzoros, C.S. (2010). Walnut consumption increases satiation but has no effect on insulin resistance or the metabolic profile over a 4-day period. Obesity 18:1176–1182.
  • Campbell, B. C., Molyneux, R. J. and Schatzki, T. F. (2003). Current research on reducing pre- and post-harvest aflatoxin contamination of US almond, pistachio, and walnut. J. Toxicol. Toxin. Rev. 22:225–266.
  • Carrion, J. S., Fuentes, N., Gonzalez-Samperiz, P., Sanchez Quirante, L., Finlayson, J. C., Fernandez, S. and Andrade, A. (2007). Holocene environmental change in a montane region of southern Europe with a long history of human settlement. Quat. Sci. Rev. 26(11–12):1455–1475.
  • Carvalho, M., Ferreira, P. J., Mendes, V. S., Silva, R., Pereira, J. A. and Jerónimo, C. (2010). Human cancer cell antiproliferative and antioxidant activities of Juglans regia L. Food Chem. Toxicol. 48:441–447.
  • Casas-Agustench, P., Lopez-Uriarte, P., Ros, E., Bullo, M. and Salas-Salvado, J. (2011a). Nuts, hypertension and endothelial function. Nutr. Met. Cardiovasc. Dis. 21(Suppl. 1):S21–S33.
  • Casas-Agustench, P., Salas-Huetos, A. and Salas-Salvado, J. (2011b). Mediterranean nuts: Origins, ancient medicinal benefits and symbolism. Public Health Nutr. 14(Suppl. 1):2296–2301.
  • Cerda, B., Tomas-Barneran, F. A. and Espin, J. C. (2005). Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: Identification of biomarkers and individual variability. J. Agric. Food Chem. 53:227–235.
  • Chen, C. Y. and Blumberg, J. B. (2008). Phytochemical composition of nuts. Asia Pacific J. Clinic. Nut. 17(Suppl. 1):329–332.
  • Colditz, G. A., Burdick, E. and Mosteller, F. (1995). Heterogeneity in meta-analysis of data from epidemiologic studies: A commentary. Am. J. Epidemiol. 142:371–382.
  • Colditz, G.A., Manson, J.E., and Hankinson, S.E. (1997). The Nurses' Health Study: 20-Year Contribution to the Understanding of Health Among Women. J Women's Health. 6(1): 49–62.
  • Czernichow, S., Thomas, D. and Bruckert, E. (2010). n-6 Fatty acids and cardiovascular health: A review of the evidence for dietary intake recommendations. Br. J. Nutr. 104:1–9.
  • Daniel, E. M., Krupnick, A. S., Heur, Y. H., Blinzler, J. A., Nims, R. W. and Stoner, G. D. (1989). Extraction, stability, and quantitation of ellagic acid in various fruits and nuts. J. Food Comp. Anal. 2:338–349.
  • Davis, P., Valacchi, G., Pagnin, E., Shao, Q., Gross, H. B., Calo, L. and Yokoyamaz, W. (2006). Walnuts reduce aortic ET-1 mRNA levels in hamsters fed a high-fat, atherogenic diet. J. Nutr. 136:428–432.
  • Davis, P. A., Vasua, V. T., Gohila, K., Kima, H., Khana, I. H., Carroll, E. and Yokoyama, W. (2012). A high-fat diet containing whole walnuts (Juglans regia) reduces tumour size and growth along with plasma insulin-like growth factor 1 in the transgenic adenocarcinoma of the mouse prostate model. Brit. J. Nutr. 108:1–9.
  • Din, J. N., Aftab, S. M., Jubb, A. W., Carnegy, F. H. and Lyall, K. (2011). Effect of moderate walnut consumption on lipid profile, arterial stiffness and platelet activation in humans. Eur. J. Clin. Nutr. 65:234–239.
  • Doll, R. and Peto, R. (1981). The causes of cancer in the United States today. J. Nat. Cancer Inst. 66:1192–1308.
  • Elmadfa, I. and Kornsteiner, M. (2009). Dietary fat intake – A global perspective. Ann. Nutr. Metab. 54(Suppl. 1):8–14.
  • Espin, J. C., Garcia-Conesa, M. T. and Tomas-Barberan, F. A. (2007). Nutraceuticals: Facts and fiction. Phytochemistry. 68:2896–3008.
  • Espin, J. C., Gonzalez-Barrio, R. and Cerda, B. (2007). Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans. J. Agric. Food Chem. 55:10476–10485.
  • Feldman, E. B. (2002). The scientific evidence for a beneficial health relationship between walnuts and coronary heart disease. J. Nutr. 132:1062S–1101S.
  • Ford, E. S., Williamson, D. F. and Liu, S. (1997). Weight change and diabetes incidence: Findings from a national cohort of US adults. Am. J. Epidemiol. 146:214–222.
  • Fukuda, T., Ito H. and Yoshida, T. (2003). Antioxidative polyphenols from walnuts (Juglans regia L.). Phytochemistry. 63:795–801.
  • Gao, X., Cassidy, A., Schwarzschild, M. A., Rimm, E. B. and Ascherio, A. (2012). Habitual intake of dietary flavonoids and risk of Parkinson's disease. Neurology. 78:1138–1145.
  • Gerber, M. (2009). Background review paper on total fat, fatty acid intake and cancers. Ann. Nutr. Metab. 55:140–161.
  • Gillen, L. S. and Tapsell, L. C. (2005). Structured dietary advice incorporating walnuts achieves optimal fat and energy balance in patients with type 2 diabetes mellitus. J. Am. Diet. Assoc. 105:1087–1096.
  • Gunduc, N. and El, S. N. (2003). Assessing antioxidant activities of phenolic compounds of common Turkish food and drinks on in vitro low-density lipoprotein oxidation. J. Food Sci. 68:2591–2595.
  • Hamazaki, T. and Okuyama, H. (2003). The Japan society for lipid nutrition recommends to reduce the intake of linolenic acid. A review and critique of the scientific evidence. In Omega-6/Omega-3 Essential Fatty Acid Ratio: The scientific evidence, volume eds. A P Simopoulos and L G Cleland. World Rev. Nutr. Diet. 92:109–132.
  • Han, Y. S., Bastianetto, S., Dumont, Y. and Quirion, R. (2006). Specific plasma membrane binding sites for polyphenols, including resveratrol, in the rat brain. J. Pharmacol. Exp. Ther. 318:238–245.
  • Hardman, W. E. and Ion, G. (2008). Suppression of implanted MDA-MB 231 human breast cancer growth in nude mice by dietary walnut. Nutr. Cancer 60:666–674.
  • Hardman, W. E., Ion, G., Akinsete, J. A. and Witte, T. R. (2011). Dietary walnut suppressed mammary gland tumorigenesis in the C(3)1 TAg mouse. Nutr. Cancer. 63:960–970.
  • Harnly, J. M., Doherty, R. F., Beecher, G. R., Holden, J. M., Haytowitz, D. B., Bhagwat, S. and Gebhardt, S. (2006). Flavonoid content of US fruits, vegetables, and nuts. J. Agric. Food. Chem. 54:9966–9977.
  • Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G., Liu, S., Solomon, C. G. and Willett, W. C. (2001). Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N. Engl. J. Med. 345:790–797.
  • Hu, F. B., Stampfer, M. J. and Rimm, E. (1999). Dietary fat and coronary heart disease. Am. J. Epidemiol. 149:531–540.
  • Huang, P., Chandra, V. and Rastinejad, F. (2010). Structural overview of the nuclear receptor superfamily: Insights into physiology and therapeutics. Ann. Rev. Physiol. 72:247–272.
  • International Nut and Dried Fruit Foundation. (2010). Nuts and Dried Fruits Global Statistical Review 2004–2009. INC, Reus, Spain.
  • Ito, H. Okuda, T., Fukuda, T., Hatano, T. and Yoshida, T. (2007) Two novel dicarboxylic acid derivatives and a new dimeric hydrolysable tannin from walnuts. J. Agric. Food Chem. 55:672– 679.
  • Jiang, R., Manson, J. E., Stampfer, M. J., Liu, S., Willett, W. C. and Hu, F. B. (2002). Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA 288:2554–2560.
  • Jiang W., Oken H., Fiuzat M., Shaw, L.K., Martsberger, C., Kuchibhatla, M., Kaddurah-Daouk, R., Steffens, D.C., Baillie, R., Cuffe, M., Krishnan, R. and O’Connor, C. (2012). Plasma omega-3 polyunsaturated fatty acids and survival in patients with chronic heart failure and major depressive disorder. J Cardiovasc Transl Res. 5:92–99.
  • Joseph, J. A., Shukitt-Hale, B. and Willis, L. M. (2009). Grape juice, berries, and walnuts affect brain aging and behavior. J. Nutr. 139:1813S–1817S.
  • Kagawa, Y. (2001). In: Standard Tables of Food Composition in Japan. Kagawa Nutrition University Press, Tokyo, Japan.
  • Kendall, C. W. C., Esfahani, A., Josse, A. R., Augustin, L. S. A., Vidgen, E. and Jenkins, D. J. A. (2011). The glycaemic effect of nut-enriched meals in healthy and diabetic subjects. Nutr. Metab. Cardiovasc. Dis. 21(Suppl. 1):S34–S39.
  • Keys, A., Anderson, J. T. and Grande, F. (1957). Prediction of serum-cholesterol responses of man to changes in the diet. Lancet. 273:959–966.
  • Knol, M. J., Twisk, J. W., Beekman, A. T., Heine, R. J., Snoek, F. J. and Pouwer, F. (2006). Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia. 49:837–845.
  • Kolb, H. and Mandrup-Poulsen, T. (2005). An immune origin of type 2 diabetes? Diabetologia. 48:1038–1050.
  • Kolb, H. and Mandrup-Poulsen, T. (2010). The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia. 53:10–20.
  • Kuo, P. T., Whereat, A. F., Bassett, D. R. and Ezra. (1961). Patterns of hyperlipaemic patients before and after the ingestion of different study of the mechanism of hyperlipaemia: Serum chylomicron fatty acid. Circulation. 24:213–222.
  • Labuckas, D. O., Maestri, D. M., Perello, M., Martinez, M. L. and Lamarque, A. L. (2008). Phenolics from walnut (Juglans regia L.) kernels: Antioxidant activity and interactions with proteins. Food Chem. 107:607–612.
  • Larsson, S. C., Kumlin, M., Ingelman-Sundberg, M. and Wolk, A. (2004). Dietary long-chain n-3 fatty acids for the prevention of cancer: A review of potential mechanisms. Am. J. Clin. Nutr. 79:935–945.
  • Li, L., Tsao, R., Yang, R., Kramer, J. and Hernandez, M. (2007). Fatty acid profiles, tocopherol contents, and antioxidant activities of heartnut (Juglans ailanthifolia var. cordiformis) and Persian walnut (Juglans regia L.). J. Agric. Food Chem. 55:1164–1169.
  • Maguire, L. S., O'sullivan, S. M., Galvin, K., O'Connor, T. P. and O'Brien, N. M. (2004). Fatty acid profile, tocopherol, squalene and phytosterol content of walnuts, almonds, peanuts, hazelnuts and the macadamia nut. J. Food Sci. Nutr. 55:171–178.
  • Manninen, V., Olli Elo, M., Heikki, F., Kauko, H., Heinonen, O., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Mäenpää, H., Mälkönen, M., Mänttäri, M., Norola, S., Pasternack, A., Pikkarainen, J., Romo, M., Sjöblom, T. and Nikkilä, E. A. (1988). Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. J. Am. Med. Assoc. 260:641–651.
  • Mantzoros, C. S., Williams, C. J., Manson, J. E., Meigs, J. B. and Hu, F. B. (2006). Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women. Am. J. Clin. Nutr. 84:328–335.
  • Martinez-Gonzalez, M. A., Corella, D., Salas-Salvado, J., Ros, E., Covas, M. I., Fiol, M., Warnberg, J., Aros, F., Ruiz-Gutierrez, V., Lamuela-Raventos, R. M., Lapetra, J., Munoz, M. A., Martinez, J. A., Saez, G., Serra-Majem, L., Pinto, X., Mitjavila, M. T., Tur, J. A., Portillo, M. D., Estruch, R. and the PREDIMED Study Investigators. (2010). Cohort profile: Design and methods of PREDIMED study. Int. J. Epidemiol. 41(2):377–385.
  • Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F. and Turner, R. C. (1985). Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:412–419.
  • Mazza, M., Pomponi, M., Janiri, L., Bria, P. and Mazza, S. (2007). Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: An overview. Prog. Neuro.Psychopharmacol. Biol. Psych. 31:12–26.
  • Medina-Remon, A., Barrionuevo-Gonzalez, A., Zamora-Ros, R., Andres-Lacueva, C., Estruch, R., Martina-Gonzalez, M. A., Diez-Espino, J. and Lamuela-Raventos, R. M. (2009). Rapid Folin-Ciocalteu method using microtiter 96-well plate cartridges for solid phase extraction to assess urinary total phenolic compounds as a biomarker of total polyphenol intake. Anal. Chim. Acta 634: 54–60.
  • Mensink, R. P., Zock, P. L., Kester, A. D. and Katan, M. B. (2003). Effect of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 77:1146–1155.
  • Mente, A., de Koning, L., Shannon, H. S. and Anand, S. S. (2009). A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch. Intern. Med. 169:659–669.
  • Micha, R. and Mozaffarian, D. (2010). Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: A fresh look at the evidence. Lipids. 45:893–905.
  • Molendi-Coste, O., Legry, V. and Leclercq, I. A. (2011). Why and how meet n-3 PUFA Dietary Recommendations? Gastroenterol. Res. Pract. 2011:364.
  • Nagel, J.M., Brinkoetter, M., Magkos, F., Liu, X., Chamberland, J.P., Shah, S., Zhou, J., Blackburn, G., and Mantzoros, C.S. (2012). Dietary walnuts inhibit colorectal cancer growth in mice by suppressing angiogenesis. Nutrition. 28:67–75.
  • Nagel, J.M., Brinkoetter, M., Magkos, F., Liu, X., Chamberland, J.P., Shah, S., Zhou, J., Blackburn, G. and Mantzoros, C.S. (2012). Dietary walnuts inhibit colorectal cancer growth in mice by suppressing angiogenesis. Nutrition. 28:67–75.
  • News Review. 2010. Lipid technology 5/2010. Lipid Technol. 22:99–102.
  • Ohashia, K., Ouchia, N. and Matsuzawab, Y. (2012). Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie. 94:21137–2142.
  • Oshaghi1, E. A., Sorkhani, A. N. and Rezaei1, A. (2012). Effects of walnut on lipid profile as well as the expression of sterol-regulatory element binding protein-1c(SREBP-1c) and peroxisome proliferator activated receptors α (PPARα) in diabetic rat. Food Nutri. Sci. 3:255–259.
  • Ouchi, N., Kobayashi, H., Kihara, S., Kumada, M., Sato, K., Inoue, T., Funahashi, T. and Walsh, K. (2004). Adiponectin stimulates angiogenesis by promoting cross-talk between AMP activated protein kinase and Akt signaling in endothelial cells. J. Biol. Chem. 279:1304–1309.
  • Papoutsi, Z., Kassi, E., Chinou, I., Halabalaki, M., Skaltsounis, L. A. and Moutsatsou, P. (2008). Walnut extract (Juglans regia L.) and its component ellagic acid exhibit anti-inflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483. Br. J. Nutr. 99:715–722.
  • Park, E. J. and Pezzuto, J. M. (2012). Flavonoids in cancer prevention. Anticancer Agents Med. Chem. 12(8):836–851.
  • Pribis, P., Bailey, R. N., Russell, A. A., Kilsby, M. A., Hernandez, M., Craig, W. J., Grajales, T., Shavlik, D. J. and Sabate, J. (2012). Effects of walnut consumption on cognitive performance in young adults. Br. J. Nutr. 107:1393–1401.
  • Rey, A. (1964). L'examen Clinique en Psychologie. Presses Universitaires de France, Paris, France.
  • Ros, E. (2009). Nuts and novel biomarkers of cardiovascular disease. Am. J. Clin. Nutr. 89:1649S–1656S.
  • Ros, E., Nunez, I., Perez-Heras, A., Serra, M., Gilabert, R. and Casals, E. (2004). A walnut diet improves endothelial function in hypercholesterolemic subjects: A randomized crossover trial. Circulation. 109:1609–1614.
  • Russo, G. L. (2009). Dietary n-6 and n-3 polyunsaturated fatty acids: From biochemistry to clinical implications in cardiovascular prevention. Biochem. Pharmacol. 77:937–946.
  • Sabate, J. (1993). Does nut consumption protest against ischemic heart disease? Eur. J. Clin. Nutr. 47:71–5S.
  • Sabate, J., Cordero-Macintyre, Z., Siapco, G., Torabian, S. and Haddad, E. (2005). Does regular walnut consumption lead to weight gain? Br. J. Nutr. 94:859–864.
  • Salas-Salvado, J., Bullo, M., Babio, N., Martinez-Gonzalez, M., Ibarrola-Jurado, N., Basora, J., Estruch, R., Covas, M., Corella, D., Aros, F., Ruiz-Gutierrez, V. and Ros, E. (2011). Reduction in the incidence of type 2 diabetes with the mediterranean diet. Diabetes Care. 34:14–19.
  • Shakibaei, M., Harikumar, K. B. and Aggarwal, B. B. (2009). Resveratrol addiction: To die or not to die. Mol. Nutr. Food Res. 53:115–128.
  • Shaw, J. E, Sicree, R. A. and Zimmet, P. Z. (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87:4–14.
  • Shu, H., Wong, B., Zhou, G., Li, Y., Berger, J., Woods, J. W., Wright, S. D. and Cai, T. Q. (2000). Activation of PPARα or γ reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells. Biochem. Biophys. Res. Commun. 267:345–349.
  • Simon, J. A., Chen, Y. H. and Bent, S. (2009). The relation of a-linolenic acid to the risk of prostate cancer: A systematic review and meta-analysis. Am. J. Clin. Nutr. 89(Suppl):1558S–1596S.
  • Simopoulos, A. P. (2008). The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp. Biol. Med. 233:674–688.
  • Singh, P., Kumar, A., Dubey, N. K. and Gupta, R. (2009). Essential oil of Aegle marmelos as a safe plant-based antimicrobial against postharvest microbial infestations and aflatoxin contamination of food commodities. J. Food Sci. 74:302–307.
  • Singleton, V. L., Orthofer, R. and Lamuela-Raventos, R. M. (1999). Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Methods Enzymol. 299:152–178.
  • Siri-Tarino, P. W, Sun, Q., Hu, F. B. and Krauss, R. M. (2010). Saturated fat, carbohydrate, and cardiovascular disease. Am. J. Clin. Nutr. 91:502–509.
  • Smoliga, J. M., Baur, J. A., and Hausenblas, H. A. (2011). Resveratrol and health – A comprehensive review of human clinical trials. Mol. Nutr. Food Res. 55:1129–1141.
  • Spaccarotella, K. J., Kris-Etherton, P. M., Stone, W. L., Bagshaw, D. M., Fishell, V. K., West, S. G., Lawrence, F. R. and Hartman, T. J. (2008). The effect of walnut intake on factors related to prostate and vascular health in older men. Nutr. J. 2:7–13.
  • Spranger, J., Mohlig, M., Wegewitz, U., Ristow, M., Pfeiffer, A. F., Schill, T., Schlosser, H.W. Brabant, G. and Schofl, C. (2004). Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. Clin. Endocrinol. 61:738–746.
  • Steppan, C. M., Bailey, S. T., Bhat, S. S., Brown, E.J., Banerjee, R.R., Wright,C.M., Hiralben R. Patel, Ahima R.S. and Lazar, M.A. (2001). The hormone resistin links obesity to diabetes. Nature. 409:307–312.
  • Stoner, G. D. and Mukhtar, H. (1995). Polyphenols as cancer chemopreventive agents. J. Cell Biochem. Suppl. 22:169–180.
  • Sze-Tao, K. W., Schrimpf, J. E., Teuber, S. S., Roux, K. H. and Sathe, S. K. (2001). Effects of processing and storage on walnut (Juglans regia L.) tannins. J. Sci. Food Agric. 81:1215–1222.
  • Tapsell, L. C., Gillen, L. J., Patch, C. S., Batterham, M., Owen, A., Baré, M. and Kennedy, M. (2004). Including walnuts in a low-fat/modified-fat diet improves HDL cholesterol-to-total cholesterol ratios in patients with type 2 diabetes. Diabetes Care. 27:2777–2783.
  • Torabian, S., Haddad, E., Cordero-Macintyre, Z., Tanzman, J., Fernandez, M. L. and Sabate, J. (2010). Long-term walnut supplementation without dietary advice induces favorable serum lipid changes in free-living individuals. Eur. J. Clin. Nutr. 64:274.
  • Umesalma, S. and Sudhandiran, G. (2011). Ellagic acid prevents rat colon carcinogenesis induced by 1, 2 dimethyl hydrazine through inhibition of AKT-phosphoinositide-3 kinase pathway. Eur. J. Pharmacol. 660:249–258.
  • U.S. Department of Agriculture Nutrient Data Base at http://ndb.nal.usda.gov/ndb/search Accessed 2012.
  • Valls-Pedret, C., Lamuela-Raventos, R. S., Medina-Remon, A., Quintana, M., Dolores, C., Pinto, X., Martinez-Gonzalez, M. A., Estruch, R. and Ros, E. (2012). Polyphenol-rich foods in the Mediterranean diet are associated with better cognitive function in elderly subjects at high cardiovascular risk. J. Alzheimer's Dis. 29:773–782.
  • Vinson, J. A. and Cai, Y. (2011). Nuts, especially walnuts, have both antioxidant quantity and efficacy and exhibit significant potential health benefits. Food Funct. 3:134–140.
  • Vinson, J. A. and Honz, B. A. (1995). Phenol antioxidant index: Comparative antioxidant effectiveness of red and white wines. J. Agric Food Chem. 43:401–403.
  • Visioli, F., Lastra, C. A. and Andres-Lacueva, C. (2011). Polyphenols and human health: A prospectus. Crit. Rev. Food Sci. Nutr. 51:524–546.
  • Willett, W. C. (2012). Dietary fats and coronary heart disease. J. Int. Med. 272:13–24.
  • Williams, C. D., Whitley, B. M., Hoyo, C., Grant, D. J., Iraggi, J. D., Newman, K. A., Gerber, L., Taylor, L. A., McKeever, M. G. and Freedland, S. J. (2011). A high ratio of dietary n-6/n-3 polyunsaturated fatty acids is associated with increased risk of prostate cancer. Nutr. Res. 31:1–8.
  • Willis, L. M., Shukitt-Hale, B., Cheng, V. and Joseph, J. A. (2009). Dose-dependent effects of walnuts on motor and cognitive function in aged rats. British J. Nutr. 101, 1140–1144.
  • Wood, A. W., Huang, M. T., Chang, R. L., Newmark, H. L., Lehr, R. E., Yagi, H., Sayer, J. M., Jerina, D. M. and Conney, A. H. (1982). Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occurring plant phenols exceptional activity of ellagic acid. Proc. Nat. Acad Sci. 79:5513–5517.
  • Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., Ezaki, O., Akanuma, Y., Gavrilova, O., Vinson, C., Reitman, M. L., Kagechika, H., Shudo, K., Yoda, M., Nakano, Y., Tobe, K., Nagai, R., Kimura, S., Tomita, M., Froguel, P. and Kadowaki, T. (2001). The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7:941–946.
  • Ziemke, F. and Mantzoros, C. S. (2010). Adiponectin in insulin resistance: Lessons from translational research. Am. J. Clin. Nutr. 91(Suppl.):258S–261S.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.